APA (7th ed.) Citation

R, Z., Y, L., X, N., X, D., & G, W. (2016). Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations. Dove Medical Press.

Chicago Style (17th ed.) Citation

R, Zhang, Li Y, Nie X, Dong X, and Wu G. Prognostic Implications of Immunohistochemistry Markers for EGFR-TKI Therapy in Chinese Patients with Advanced Lung Adenocarcinoma Harboring EGFR Mutations. Dove Medical Press, 2016.

MLA (8th ed.) Citation

R, Zhang, et al. Prognostic Implications of Immunohistochemistry Markers for EGFR-TKI Therapy in Chinese Patients with Advanced Lung Adenocarcinoma Harboring EGFR Mutations. Dove Medical Press, 2016.